Age Management Medicine Group > Archives > November 11-14, 2010 > Agenda (Nov 20010)
       


 

Thursday, November 11
 
7:00 am - 7:45 am 
The Clinical Aspects of Helping Your Patients Feel Good, Look Younger and Have Better Sex
Presented by Edwin Lee, M.D. 
(includes complimentary breakfast)
Non-CME symposium sponsored by Bellevue Pharmacy

 

Pre-Conference Track 1:  Age Management Basics: Nutrition and Hormones
Course is designed to familiarize physicians and healthcare professionals with the basics of Age Management Medicine, covering evidence based use of nutrition, supplements, hormones, hormone testing and relevant case presentation and discussion.  

 

8:00 am – 10:00 am
Nutrient Strategies for the Age Management Clinician
Derrick M. DeSilva, Jr., M.D.
Chairman, AMMG Conference Planning Committee
Co-Chair, Depart of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
Teaching Faculty, JFK Medical Center, Edison, NJ
Once the ball is rolling in your practice, how do we then turn this ball into a snowball that will grow? Having the knowledge but not knowing how to implement it is a major hurdle. I will share some simple strategies as to how to integrate these supplements into any practice. This strategy will enhance and help build any practice from the ground up and also help build on to any practice that is currently functioning. I will review real-life marketing plans to grow  supplement utilization and as a result grow the practice.

 

10:00 am - 10:15 am 
Break  

 

10:15 am – 12:00 pm
Clinical Use of Supplements in the Age Management Practice
Derrick M. DeSilva, Jr., M.D.
Chairman, AMMG Conference Planning Committee
Co-Chair, Depart of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
Teaching Faculty, JFK Medical Center, Edison, NJ
There is no question that dietary supplements play a significant role in the age management process. During this lecture we will focus on the nutrients that will make a difference in our bodies as we age. The role of CoQ10, Fish Oils, Probiotics, Vitamin D, and many more will be looked at. The important issue of safety and the use of supplements along with prescription medications will also be touched upon. This presentation will be a review of the basic supplements and how to get the supplement ball rolling in your practice.

 

12:00 pm - 1:15 pm 
Lunch Break

 

1:15 pm – 3:00 pm
Bio-identical Hormone Restoration Therapy:  Essential Information for Appropriate Diagnosis and Treatment
Lena D. Edwards, M.D., FAARFM
President, Balance Health & Wellness Center, Lexington, KY
Medical Director, Seasons Salon and Spa, Lexington, KY
Community Faculty, University of Kentucky Medical Center
As patients’ interest in prophylactic and therapeutic bio-identical hormone replacement rises and the medical literature on this topic becomes more abundant, it is imperative that health care providers have a thorough understanding of how to properly diagnose and treat sex hormone imbalances while maintaining balance among other hormonal systems. This discussion will review the essential functions of the sex hormones as well as potential symptoms of sex hormone imbalance. Clinical case studies will be used to discuss how to properly diagnose female patients with underlying sex hormone disturbances. Clinicians will also gain a better understanding of how to properly treat signs and symptoms of sex hormone imbalances without causing adverse clinical side effects and disruption of hormonal homeostasis. Time permitting, the medical literature available highlighting side effects of oral synthetic hormone replacement and the differences between synthetic and bio-identical hormones will be reviewed.

 

3:00 pm – 3:45 pm 
Break - Visit Exhibits

 

3:45 pm – 5:30 pm
Interactive Case Discussion: Diagnosing, Management & Therapeutic Interventions
Florence Comite, M.D.
Courtesy Attending, Yale University School of Medicine, New Haven, CT
Member, AMMG Certification Committee
Steven Villagomez, M.Ed., ACSM-RCEP, NSCA-CSCS  
Exercise Physiologist, New York, NY
Over the past few years, the field of Age Management Medicine has been rapidly evolving, including new advances in diagnoses and therapies. Utilizing data gleaned from a broad population base in her Manhattan-based practice, Florence Comite, M.D. along with Steven Villagomez, M.Ed., ACSM-RCEP, NSCA-CSCS, will guide participants through several case studies, demonstrating the clinical challenges that undermine metabolic optimization. Following a comprehensive overview, conference participants will be led through the diagnoses, management and therapeutic interventions of disorders related to aging. The case studies will expose attendees to an in-depth analysis of the ongoing therapeutic process over a 6-12 month period. Diagnostic tests, hormonal optimization, lifestyle modifications and VO2 assessment will be emphasized with the outcome of health enhancement and reversal of emerging disease. This interactive, problem-based learning workshop allows for reinforcement of important practical concepts, and the development of vital skill sets to interpret and utilize diagnostic findings in individuals. 
 
 

 


Pre-Conference Track 2:  Regenerative and Cell-Based Medicine
Regenerative and cell-based medicine continue to grow in use by physicians across the world. From platelet rich plasma to culture expanded stem cells, the need for information about the applications of these therapies to treat patients has never been greater. Sponsored by the International Cellular Medicine Society, a global nonprofit with over a thousand members from 35 countries that is dedicated to physician education and patient safety, this track will focus on the latest developments in cell-based medicine with speakers who are driving the research and using these technologies as part of their everyday practice of medicine. This track will present presentations on the use of PRP, adipose, bone marrow and peripheral blood derived stem cells and data on the application of these promising therapies in providing treatment to patients today.  

 

Academic Supporter: International Cellular Medicine Society (ICMS)
Track Co-Chairs:  
Christopher J. Centeno, M.D.
L. Stephen Coles, M.D., Ph.D.

 

8:00 am - 8:05 am
Opening Remarks and Overview of the ICMS Educational Mission
David Audley
Executive Director, International Cellular Medicine Society (ICMS)

 

8:05 am - 8:30 am
Medical Innovation and Public Health: The Pyramidization of Risk and the Practice of Cell-Based Medicine
Michael D. Freeman, Ph.D., M.P.H.
Clinical Professor of Epidemiology, Department of Public Health and Preventive Medicine, Oregon Health & Sciences University School of Medicine
Adjunct Associate Professor of Forensic Medicine and Epidemiology, Institute of Forensic Medicine, Faculty of Health Sciences, University of Aarhus, Aarhus, Denmark
President, International Cellular Medicine Society (ICMS)
Dr. Freeman will describe the concept of pyramidization of public health as it relates to a one-on-one versus one-on-many risk factors in the development of novel therapeutic treatments.

 

8:30 am - 9:00 am
Exceptionalism in Stem Cell Innovation: Ethical, Political and Regulatory Issues at the Moment of Decision
Glenn McGee, Ph.D.
John B. Francis Chair in Bioethics, Center for Practical Bioethics
Editor-in-Chief, The American Journal of Bioethics
Every so often, an innovation in biomedical science disrupts previous concepts of human nature, and in particular health and disease, in a dramatic way, introducing not only new techniques but new paradigms. The first gene therapies in children, the cloning of Dolly, the cultivation of hES cells, and widespread genetic testing thus strained the capacity of clinical, regulatory, political, and patient organizations to their limits. In the face of such innovation, fear of technology, as deeply embedded in Western culture as our janus-faced love of progress, has moved even the most savvy minds to adopt a rhetoric of fear or luddism, best personified by Leon Kass' New Republic article on nuclear transfer entitled, "The wisdom of repugnance." At the same time, patients desperate for clinical innovations have asked for rapid integration of new technologies into the armamentarium of medicine, storming the halls of Congress and making stem cell research a voting issue in three presidential elections. As a result, institutions of government have pushed totally different law and policy for new technologies, so that we have not only laws regarding medical discrimination but also genetic discrimination; laws concerning transplantation of organs and also laws regarding transplantation of sperm. This "exceptionalism" almost always leads to bad science policy, incomprehensible clinical guidelines, and confusion about ethical issues like patients' rights and patient safety. Cellular therapies, to the degree that they are totally outside the scope of existing law and policy, might warrant special rules. But just as genetic exceptionalism inappropriately treated genetic testing in a special manner, many of the efforts to treat stem cell innovation as exceptional (both especially dangerous and especially subject to scrutiny when employed by physicians) are neither intelligent nor prescient. The protection of patients, and the sanctity of the distinction between clinical research and clinical innovation, are at stake in 2010 as regulators, industry organizations, patient safety organizations, patient groups, physicians, researchers and others have begun to posture prematurely in defense of "stem cell exceptionalism." I will argue that it is a mistake to treat innovation in stem cells as warranting special rules that imply that the use of a stem cell in the clinic is automatically a research effort, and further that there are better ways to build physician and organizational safety mechanisms, internationally, that lack the teeth missing in decades of "exceptional" areas such as reproductive medicine and genetic testing, where "exceptional" policies have been completely ineffective in protecting anyone or ensuring good medicine and policy.

 

9:00 am - 9:30 am
Veterinary Stem and Regenerative Cell Therapy: Real Data from Real Diseases
Robert J. Harman, D.V.M., MPVM
CEO, Vet-Stem, Inc.
Vet-Stem is commercially applying the discoveries of human regenerative medicine research to veterinary medicine.  Our primary technology is autologous, non-cultured, fat-derived stem cell therapy applied as a service to treat equine tendon, ligament and bone injuries and canine orthopedic and hepatic diseases.  The data from these real clinical cases can be utilized as proof of principle for human cell therapy and can be used to guide the selection of platforms, delivery methods, and dosing for human clinical trials.  Vet-Stem’s clients have treated of 6000 clinical cases.  Safety and efficacious dosing will be discussed, along with quality control and delivery techniques. The following data will be presented:  research results of blinded placebo-controlled trials; cell characterization, clinical efficacy, and case studies.  Implications derived from the business model and regulatory strategy and observations about public acceptance of stem cell therapy in the horse will be presented.

 

9:30 am - 10:00 am
How Very Small Embryonic Like Stem Cells Shed New Light on Mesenchymal Stem Cell Function:  New Data Supports Role of VSELs in the Regenerative Properties of MSCs
Alan G. Harris, M.D., Ph.D.  
Vice President Drug Development & Regulatory Affairs, Neostem, New York, NY
Adult multipotent stem cells such as Mesenchymal Stem Cells (MSCs) can differentiate into a limited number of cell types, thus permitting autologous cell-based therapy. This has advantages over human embryonic stem cells (hESC) with no risk of rejection and quicker engraftment. Recently discovered Very Small Embryonic-Like (VSEL) adult stem cells can be obtained from mobilization and apheresis of autologous peripheral blood thus avoiding the need for bone marrow aspiration. 
   Current studies suggest that VSELs are true pluripotent stem cells with most of the beneficial, and none of the drawbacks (e.g., tumorigenesis) of hESCs or induced pluripotent stem cells. New data supports a role of VSELs in the regenerative properties of MSCs. Unlike other ASCs, pluripotent VSELs can be used for a wide range of therapeutic applications.
   Small numbers of VSELs can provide adequate cell doses and are expandable, if necessary, and can be cryopreserved to provide a banked source for multiple regenerative treatments over time, thereby providing a lifelong deposit of pluripotent stem cells. Therapeutic applications of VSELs are being considered in wounds, bone and cartilage repair, cardiovascular diseases and other conditions.

 

10:00 am - 10:15 am
Break

 

10:15 am - 10:45 am
Platelet Rich Plasma Injection Techniques and Case Studies
Joseph Aiello, D.O.
CMO, San Diego Center for Integrative Medicine
Through lecture and case studies Dr. Aiello will discuss the use of Platelet Rich Plasma for injections and his experience with the procedure.
  
 
10:45 am – 11:15 am
Defining the Composition and Healing Affect of Platelet Rich Plasma for Use in Regenerative Medicine
Sherwin Kevy, M.D.
Investigator, Immune Disease Institute
Associate Professor Emeritus, Harvard University Medical School
Consultant, Harvest Technologies
Platelets contain growth factors and other substances that have the potential to accelerate tissue repair.  Numerous systems have been developed to produce at point of care what is called platelet-rich plasma.  The most effective concentration of the releasate of this product or its ability to promote wound healing has not been defined.  In this lecture, the effects of different concentrations of releasate and the composition of the concentrated platelet product (CPP) or tissue reparation mechanism were investigated.
 

 

11:15 am – 11:45 am
Stem Cells in the Nervous System: Data on the Applications of Bone Marrow Aspirant Concentrate
Augusto Brazzini, M.D.
Professor, San Martin University, Lima, Peru
Director, Brazzini Institute of Interventional Radiology
Vice President, Asociacion Peruana de Terapia Cellular (APTCEL)
The use of autologous bone marrow aspirate concentrate to treat Parkinson's disease will be discussed. Case reports of patients before and after treatment will be highlighted.
 

 

11:45 am - 12:00 pm
ICMS Stem Cell Registry
David Audley
Executive Director, International Cellular Medicine Society (ICMS)
 

 

12:00 pm - 1:15 pm
Lunch Break

  

1:15 pm – 1:45 pm
Adult MSCs Resurfacing Articular Joints & Factor-Induced Skeletal Muscle Regeneration
Henry E. Young, Ph.D.
Professor of Anatomy, Anesthesiology, Pediatrics Obstetrics and Gynecology, Mercer University School of Medicine
Chief Scientific Officer / Consultant, Moraga Biotechnology Corporate
Exogenous and endogenous adult-derived stem cells are showing many uses for healing damaged tissues.  Here we report two uses of these cells. First, exogenous ASCs are embedded within FDA-approved polyglycolic acid and shown to heal damaged articular cartilage. Second, factor-induced endogenous ASCs regenerate skeletal muscle with an intact neurovascular triad.
 

 

1:45 pm – 2:15 pm
A Validated Method for the Isolation of Adipose Derived Stem Cells and Their Importance in Autologous Fat Graft Survival
Kristin Comella 
CEO, Stemlogix, Fort Lauderdale, FL
Chief Scientific Officer, Ageless Regenerative Institute
VP Research & Corporate Development, BioHeart, Inc.
Recent studies have identified adipose tissue as an alternate source of stem cells. The procedure for obtaining adipose derived stem cells (ADSCs) from the patient is a relatively simple process and tolerated by most patients. Fat tissue can usually be found in abundance within the patient’s own body and has a greater number of stem cells than bone marrow. ADSCs can be used at the site of injury or disease, as well as for soft tissue defects and fat transfer. Regenerative cells may amplify the body’s own repair process, accelerate healing, repair damaged and diseased tissue, and prevent scarring and loss of function. ADSCs have demonstrated angiogenic properties and can provide a practical approach to tissue vascularization. We have developed a standardized harvesting process for adipose tissue and the isolation of ADSCs. This advancement in collection of ADSCs makes the procedure more predictable and reliable, which is especially important in treatment of degenerative diseases. These techniques are currently being utilized in the clinic for a variety of indications.
 

 

2:15 pm - 2:45 pm
Adipose Derived Adult Stem Cells: History, Current Use and Future Developments in Treating Critical Limb Ischemia 
Jeong Chan Ra, D.V.M., Ph.D.
Adjunct Professor, College of Veterinary Medicine, Seoul National University, Seoul, South Korea
CEO, RNL Bio Ltd., Seoul, South Korea
Adipose derived MSC's hold great promise for regenerative medicine. The use of culture expanded MSC's to treat critical limb ischemia and help patients avoid amputation will be discussed. Before and after photos of treated limbs and vascular studies will be reviewed.

 

2:45 pm – 3:15 pm
Clinical Use of a Single-Setting Autologous Adipose Derived Stromal Cells Procedure: Lessons Learned To Date
Vasilis Paspaliaris, M.D.
Director / Founder, Adistem, Hong Kong
Visiting Professor, Institute of Integrative medicine, Indian Open University, Calcutta, India
The presentation will give an introduction into the procedure, how it has evolved into a clinical setting over four years, and where its medical benefits and limitations lie. It will conclude with what the outcome of such clinical research has been.

 

3:15 pm – 4:00 pm
Break - Visit Exhibits

 

4:00 pm - 4:30 pm
Heart Failure Improvement with Minimal Invasive Delivery of Stem Cells
Jorge Tuma Mubarak, M.D.
Chairman, International Cardiology and Regenerative Medicine, Maison De Sante Clinic, Lima, Peru
Member, Latin American Society of Interventional Cardiology and Latin American Society of Stem Cell Therapy
4 Year follow-up reporting on successful retreatment of refractory angina by the use of minimally invasive delivery of stem cells.

 

4:30 pm – 5:00 pm
Bone Marrow Derived Stem Cells In The Treatment Of Diabetes Type 1
Alejandro D. Mesples, M.D.
Interventional Cardiologist, Associate Professor of Clinical Research Service, University of Moron, School of Medicine, Argentina
Scientific Advisor and Principal Investigator, Stematix, Houston, TX
The use of bone marrow aspirate concentrate to treat type II and type I diabetes will be discussed. Serum glucose and H1AC levels before and after treatment will be highlighted.

 

5:00 pm - 5:30 pm
The Use of Mesenchymal Stem Cells in Lumbar Degenerative Disc Disease
John R. Schultz, M.D., DABPM
Co-Medical Director, Centeno-Schultz Clinic, Westminster, CO
The results of a 5-year study of the use of BMAC and two different preparations of mesenchymal stem cells to treat lumbar disc bulges will be presented. Before and after high filed MRI's will be reviewed as well as patient reported outcomes will be reviewed.

 

5:30 pm - 6:00 pm
Turning Stem Cells Into Medicine: Current Therapeutic Modalities
Zannos G. Grekos, M.D., FAAC, FACC
Director of Cardiology and Vascular Diseases, Regnocyte Therapeutic, Bonita Springs, FL
Clinical Assistant Professor, Nova Southeastern University
We conducted a study to investigate the feasibility, safety, and clinical outcome of patients with Ischemic Cardiomyopathy treated with Autologous Angiogenic and Cardio- Regenerative Progenitor cells (ACRPC's) in a prospective fashion. Both in world scientific literature as well as our experience in greater than 300 patients there is evidence of sustained improvement in the ejection fractions of patients treated with ARPC's. Animal experiments, not only show improvement in cardiac function, but also engraftment and differentiation of ACRPC's into cardiomyocytes as well as neo-vascularization in infracted myocardium. In our human clinical experience the process has shown to be safe as well as effective. This study suggests that ACRPC's can improve the ejection fraction in patients with severely reduced cardiac function with benefits sustained to six months. The goal of this presentation is to facilitate understanding of the different types of stem cells, Identifying the therapeutic benefits of stem cells, and applying current treatments to patient populations.

 

6:30 pm 
 ICMS Member Meeting & Member Reception
 
 
 
Pre-Conference Track 3:  Alternative Medicine Therapies for Stress, Pain, and Insomnia 
Emotional stress, pain, and insomnia are known to contribute to the detrimental effects of aging on the body and increase the risk for medical morbidity (e.g., metabolic syndrome, obesity) and mortality. This workshop will cover the theoretical aspects, empirical evidence, and practical applications for three psychosocial techniques for treating these conditions: hypnosis for pain management, cognitive behavioral coaching for stress management and insomnia and mindfulness meditation for emotional stress. The workshop will be a unique blend of didactic information, clinical case discussions, and experiential components so that participants will be able to 1) complete assessments for emotional stress, pain, and insomnia, and 2) understand the application of these alternative medicine techniques (hypnosis, cognitive-behavioral coaching, and meditation) for their patients. By learning techniques that mitigate against the detrimental effects of stress on the brain, participants will be able to help their patients better benefit from medical interventions.
Track Chair: Eva M. Szigethy, M.D., Ph.D.
 
8:00 am - 8:15 am
Introduction of the Speakers and Brief Overview of the Track
Eva M. Szigethy, M.D., Ph.D.
Associate Professor of Psychiatry & Director of Medical Coping Clinic, University of Pittsburgh Medical Center, Harvard Medical School
Behavioral Consultant, Empire Investigation

 

8:15 am - 10:00 am
Utilizing Hypnosis as Part of Integrative Mind-Body Healing of Chronic and Acute Pain 
Mark B. Weisberg, Ph.D., ABPP
Clinical Psychologist, Minnesota Head and Neck Pain Clinic, St. Paul, MN
Overview of the definition and assessment of acute and chronic pain and underlying psychoneuroimmunological mechanisms. Including a tutorial on theory and application of hypnotic techniques for managing pain. A combination of didactic and experiential audience components will be utilized. 
 
10:00 am - 10:15 am
Break
 
10:15 am - 11:00 am
Demonstration of Hypnosis Techniques 
Eva M. Szigethy, M.D., Ph.D. 
Associate Professor of Psychiatry & Director of Medical Coping Clinic, University of Pittsburgh Medical Center, Harvard Medical School
Behavioral Consultant, Empire Investigation
Mark B. Weisberg, Ph.D., ABPP
Clinical Psychologist, Minnesota Head and Neck Pain Clinic, St. Paul, MN

 

11:00 am - 12:00 pm 
Mindfulness Meditation in Medicine
Carol M. Greco, Ph.D
Licensed Psychologist, Center for Integrative Medicine, University of Pittsburgh, Pittsburgh, PA
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA

 

12:00 pm - 1:15 pm
Lunch Break

 

1:15 pm - 2:00 pm  
Demonstration of Mindfulness Meditation Techniques 
Carol M. Greco, Ph.D.
Licensed Psychologist, Center for Integrative Medicine, University of Pittsburgh, Pittsburgh, PA
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA

 

2:00 pm - 3:00 pm  
Neuropsycholological Assessment for Emotional Stress and Insomnia 
Eva M. Szigethy, M.D., Ph.D.
Associate Professor of Psychiatry & Director of Medical Coping Clinic, University of Pittsburgh Medical Center, Harvard Medical School
Behavioral Consultant, Empire Investigation
Carol M. Greco, Ph.D
Licensed Psychologist, Center for Integrative Medicine, University of Pittsburgh, Pittsburgh, PA
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA
 
3:00 pm - 3:45 pm
Break - Visit Exhibits
 
3:45 pm - 4:45 pm  
Cognitive Behavioral Coaching for Stress and Insomnia 
Eva M. Szigethy, M.D., Ph.D.
Associate Professor of Psychiatry & Director of Medical Coping Clinic, University of Pittsburgh Medical Center, Harvard Medical School
Behavioral Consultant, Empire Investigation
Objectives: 1) Neuropsychological assessment strategies will be discussed for emotional stress and insomnia; 2) Stress management techniques combining cognitive behavioral theory with practical applications including combining with medical interventions for stress and insomnia will be discussed; and 3) Empirical evidence for efficacy and neurobiological mechanisms of therapeutic action will re reviewed. Finally, the psychological theory and neurobiological underpinnings associated with the “placebo effect” and how physicians can optimize this effect in motivating client adherence in their medical clinics will also be covered.

 

4:45 pm - 5:30 pm  
Audience Questions and Case Discussions 
Eva M. Szigethy, M.D., Ph.D.
Carol M. Greco, Ph.D
Mark B. Weisberg, Ph.D., ABPP

  
 
Pre-Conference Track 4:  Office Based Aesthetic Medicine
Course is designed for physicians, healthcare professionals and estheticians who wish to add office-based aesthetics to their existing practice or expand their knowledge and current expertise with evidence based updates on aesthetic compounds and delivery systems, torso enhancement and transformation, FDA updates, non laser tattoo removal , use of soft tissue fillers and the use of stem cells for aesthetic enhancement.

 

8:00 am – 9:00 am
Efficiency and Relationship of Aesthetic Compounds & Ingredients to Recommended Delivery Systems and Demonstration 
Shelia Malmanis, L.E.
MS Skintechnical, Phoenix, AZ
In this day and age, new delivery systems are being offered due to the rapid acceleration of new active ingredients that have specific targets on the skin. Per Jon Packer, president of Centerchem..."If what you put on the skin doesn't get to the intended locations, it certainly won't have the desired activity". The right delivery of an ingredient can make even hard-to-use ingredients easier to formulate. For instance, when delivering peptides, liposomal systems are sometimes important since  not all peptides are stable. We are finding that liposomal encapsulation can be a solution to this issue..yet if we want a cosmetic active to support collagen synthesis, we need to bring it to the dermis in order for it to perform.  Learn some of the new delivery systems, and  how the importance of them will provide you the TRUE efficacy of active ingredients to reach the results your trying to obtain.

 

9:00 am - 10:00 am
Recent Innovations in Female Torso Aesthetic Transformation 
Jeffry B. Schafer, M.D., FRSM
Cosmetic & Reconstructive Surgeon, South Bay Head & Neck Medical Group/ New Image Cosmetic Surgery, Coronado, CA
Ron Shane, Ph.D., O.M.D.
Research Scholar, University of California at San Diego
Medical Consultant
This lecture discuss how younger and older women can surgically and non surgically beautify their torso and will represent the dissemination of the quintessential aspects of our text, and also how it is applicable to a clinician’s optimal medical practice. There will be a discussion of super cross-training regimens which involves weight training, the running of sprints, ballet exercises, free dancing, yoga stretches, and Taekwondo conditioning protocols. In addition, there will be a review how the over-activation of CRH engenders a compromised aesthetic appearance.  Moreover, we will also discuss the importance of optimal hormonal modulation as well as heuristic dietary regimens. Furthermore, the Zen Beauty approach to female torso enhancement likewise educates a woman how to ameliorate her body’s inner energy dynamics. We will be presenting what are the latest innovations in surgical body sculpturing such as water-assisted liposuction and how this technology can be blended with laser protocols to induce propitious skin tightening. Many cosmetic practitioners are now successfully transferring undesirable subcutaneous adiposity into a woman’s breasts. We will be demonstrating that the aesthetic field of female torso beautification represents a synergistic integration of many facets of optimal medicine.

 

10:00 am - 10:15 am 
Break  

 

10:15 am – 11:15 am
Update on FDA Regulations on the Use and Applications of Pigmentation Compounds in Aesthetic Medicine and Demonstration
Marie Piantino, L.E.
Director, Medical Division, Nouveau Contour USA
This lecture discus the application of pigment into the skin in the form of Permanent Makeup, how it differs from Tattoo and the latest rules and regulations from the FDA. Implications for use and contra indications, along with up-to-date information on equipment and pigments.

 

11:15 am – 12:00 pm
The Utilization of Low Energy Radio Frequency To Safely and Effectively Treat Vascular Lesions Including Spider Veins and Telangectasia on All Skin Types
Ronald G. Bush, M.D., FACS
Assistant Clinical Professor of Surgery, Medical College of Ohio
Director, Midwest Vein & Laser Center, Dayton, OH
Co-Director, International Venous Congress
Low power radio frequency is the process of using electrical resistivity to selectively thermocoagulate small, cosmetically unacceptable blood vessels using microbursts of high-frequency electrical energy delivered into the vessel via a hair-thin probe. The energy is converted to heat instantly, coagulating the blood and collapsing the vessel wall, yet leaving the outer layers of the skin unaffected. Some of the benefits of this unique new technology include instant results, minimal discomfort, no need for topical anesthetic and works for any skin type without risk of burns.

 

12:00 pm - 1:15 pm
Lunch Break

 

1:15 pm – 2:15 pm
Cutting Edge Breakthroughs in Cosmetic Medicine  
Jeffry B. Schafer, M.D., FRSM
Cosmetic & Reconstructive Surgeon, South Bay Head & Neck Medical Group / New Image Cosmetic Surgery, Coronado, CA
Ron Shane, Ph.D., O.M.D.
Research Scholar, University of California at San Diego
Medical Consultant
Medical practitioners are now utilizing a plethora of fascinating protocols to aesthetically improve the facial appearance of the aging phenotype. Many plastic surgeons and dermatologists are employing non-invasive procedures which increase facial volume and mitigate the deleterious effects of facial aging. Thus, they are becoming less inclined to perform highly invasive surgical protocols. Currently, clinicians are injecting adipose cells with high concentrations of stem cells into the face, and this restores youthful volume to the facial structure. Recently, we have implanted autologous adipose stem cells with the body’s own platelet derived growth factors throughout the facial dermis. Moreover, we have demonstrated that this innovative cosmetic strategy induces increased facial volume as well as exquisite epidermal/dermal aesthetic rejuvenation. Other clinicians have likewise shown that a patient’s own autologous growth factor attenuate facial deep furrows and beautifies the epidermal complex. This protocol may eventually replace the need for exogenous fillers. Furthermore, this lecture will also review how topical growth factors when combined with non-invasive laser strategies can rejuvenate the aging face and torso.
 
We will also be reporting on our most recent aesthetic stem cell research which involves the use of adipose cells to re-create the youthful facial scaffold as well as an additional sequence of dermal and subdermal injections throughout the facial surface with adipose stem cells and platelet-derived growth factors for superb textural epidermal remodeling.  

 

2:15 pm – 3:00 pm
The Art and Science of Facial Fillers and Injectables
Elie M. Ferneini, M.D., D.M.D., M.H.S.
Private Practice, Greater Waterbury Oral & Maxillofacial Surgeons, Waterbury, CT
Clinical Instructor, Department Oral and Maxillofacial Surgery, University of Connecticut School of Dental Medicine
Overview of the available facial fillers on the US market (including Restylane, Juvederm, and Radiesse). Clinical applications of each filler material will be discussed. Additionally, clinical applications of Botox/Dysport will be discussed.

 

3:00 pm – 3:45 pm 
Break - Visit Exhibits

 

3:45 pm – 4:45 pm
Effects of Bimatoprost and Its Suggested Use For Hypotrichosis: Are There Alternatives?
Glenn Yarbrough, M.D.
Owner / Medical Director, Scottsdale Dermatology, Scottsdale, AZ
This lecture discuss the use of bimatoprost as a means of enhancing hair growth. What are the concerns and side effects? Are the side effects permanent or reverseable? Can we use non-prescription solutions to create the same effect? If so, what are the alternatives, how effective are they and what could be any possible contra indication or side effects?

 

4:45 pm – 5:30 pm
Non-Surgical Management of the Aging Face
Elie M. Ferneini, M.D., D.M.D., M.H.S.
Private Practice, Greater Waterbury Oral & Maxillofacial Surgeons, Waterbury, CT
Clinical Instructor, Department Oral and Maxillofacial Surgery, University of Connecticut School of Dental Medicine
Overview of the changes of the aging face (including facial bones, soft tissue changes, and skin changes). Discuss factors that may accelerate the aging process such as sun exposure, hormonal changes, thinning of the skin, and cigarette smoking. Discussion of non-surgical treatment which includes anti-aging skincare, skin resurfacing treatment, facial fillers and injectables, as well as dental procedures. 

 

General Session Curriculum

 
Friday, November 12
 
7:00 am - 7:45 am
My Top 25 Most Controversial Questions and Answers Surrounding Bio Identical Hormone Replacement Therapy
Presented by Neal Rouzier, M.D.
(includes complimentary breakfast)
Non-CME symposium sponsored by MedQuest Pharmacy 
 
8:00 am - 8:05 am
Opening Remarks
Derrick DeSilva, Jr., M.D.
Chairman, AMMG Conference Planning Committee
Co-Chair, Depart of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
Teaching Faculty, JFK Medical Center, Edison, NJ

 

8:05 am – 8:30 am
Presentation of the Alan P. Mintz, M.D. Award 

 

8:30 am – 9:30 am
Clinical Protocols for Measuring and Managing Patient Stress
Eldred Taylor, M.D.
Medical Director, The Taylor Medical Group, Atlanta, GA
The impact of stress on health cannot be understated. Physicians need to understand the impact and physiology of stress vs. the normal response to stress and how stress effects the cardiovascular system and insulin resistance function. Clinicians will be instructed as to what evidence based tests are appropriate to measure the physiologic response to stress, TSH and how to identify and treat adrenal dysfunction and thyroid dysfunction. 

 

9:30 am - 10:15 am 
Break - Visit Exhibits

 

10:15 am – 11:15 am
The Epidemic of Non-Alcoholic Fatty Liver Disease 
Matthew Cave, M.D.
Assistant Professor, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY
Greater than one-third of adult Americans have abnormal liver enzymes and most of these elevations are believed to be due to nonalcoholic fatty liver disease or NAFLD. NAFLD occurs most commonly in late middle age, but an increasing number of children and adolescents are affected by NAFLD. NAFLD is typically regarded to be the hepatic manifestation of obesity and the metabolic syndrome, but recent data implicate environmental toxins in NAFLD. NAFLD may progress to cirrhosis and liver cancer, but it also appears to be a risk or exacerbating factor for cardiovascular disease. The pathogenesis of NAFLD is complex but includes oxidative stress, mitochondrial dysfunction, pro-inflammatory cytokines, insulin resistance and intestinal barrier dysfunction. Weight loss is the mainstay of therapy, but recent studies indicate a role for the antioxidant, Vitamin E.

 

11:15 am - 12:00 pm
Clinical Applications of Turmeric
Derrick DeSilva, M.D.
Chairman, AMMG Conference Planning Committee
Co-Chair, Depart of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
Teaching Faculty, JFK Medical Center, Edison, NJ
Turmeric is one of the hottest supplements on the market today. The clinical applications from decreasing inflammation to decreasing the incidence of Alzheimer disease, and the role that turmeric plays in cancer will be discussed during the presentation. The issue of instability and the rapid oxidation of this raw material along with the real science and current clinical trials will be reviewed. 

 

12:00 pm - 1:15 pm 
Lunch Break

 

12:00 pm – 1:00 pm
Physician Opportunities in Age Management Medicine: Your Path to a Successful Age Management Medicine Practice
Open to all attendees and includes a complimentary lunch
Featuring John E. Adams, Cenegenics President and Chief Executive Officer
To reserve your space or for more information call 702.953.1516 or email jhopkins@cenegenics.com.
Non-CME symposium sponsored by Cenegenics Medical Institute

 

1:15 pm – 2:15 pm
Hormones and Cancer
Neal Rouzier, M.D.
Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA
It is commonly accepted fact that hormones can cause cancer, thanks to the WHI trial. Any mention of hormones suddenly brings fear of cancer, no matter what the hormone. Most of the world’s literature supports harmful effects of medroxyprogesterone (MPA). Nevertheless, a plethora of data and studies demonstrate that many hormones protect against the cancers we so often fear. This review will put to rest the commonly held notion that all hormones cause cancer as some definitely do and many absolutely do not. The purpose of this review is to review the medical literature in regards to which hormones cause cancer and which are protective against cancer based on our medical literature. This presentation will provide literature for both physicians and patients so that they come to understand optimal replacement of hormones decreases overall morbidity and mortality from cardiovascular disease, musculoskeletal disease, and cancer. Finally we will review the pathophysiology of cancer protection via hormones and their effect on up regulation of genes, decrease in visceral fat, and production of protective proteins.

 

2:15 pm – 3:00 pm
Cancer Prevention and Treatment using Antioxidant, Antiangiogenesis and Immune Enhancement Supplements in Cancer
Jerry T. Thornthwaite, Ph.D.
Professor, Department of Physical Sciences, Freed Hardeman University, Henderson, TN
Director, Cancer Research Institute of West Tennessee
Co-Owner, Scientific Formulations
Antioxidant, antiangiogenesis and immune enhancement treatments may facilitate current classical treatments in fighting cancer. There are an increasing number of scientific publications that  show nutritional supplements play important roles in counteracting the formation and propagation of cancer. These supplements include the following: Acetyl L-Carnitine (ALC), Alpha Lipoic Acid (ALA), Coenzyme Q10 (CoQ10), Curcumin with Peperine, Genistein, Lentinan, N-AcetylCysteine (NAC), Resveratrol, selenium, Vitamin B Complex, Vitamin C, Vitamin E  and zinc.   These ingredients have been demonstrated, either individually or collectively, to have antioxidant, anti-angiogenesis, and immune stimulation properties. Furthermore, the scientific literature supports direct cancer cell cytotoxicity for Curcumin, Geinstein and NAC. The Formulation component activities are supported by over 13,000 references in the scientific literature (PubMed.com) and over 1,200 clinical trials (clinicaltrials.gov). From the literature there is evidence that some of the antiangiogenesis components affect the majority if not all pathways of angiogenesis when used in combination. Furthermore, Curcumin, Genistein and NAC actually stimulate the in vivo production of natural antiangiogenic compounds which include Angiostatin, Endostatin and Thrombospotin 1. All of the above components play a role in serving as either water or lipid soluble (able to cross the blood-brain barrier) antioxidants. Curcumin, Genistein, Resveratrol, Lentinen, NAC, zinc, selenium and the B and C vitamins all stimulate the immune system. Except for ALC and CoQ10, the other components show anti-inflammatory activity. ALC, Resveratrol along with the B and C vitamins are helpful in treating fatigue.
 
The components that help protect the brain and promote nerve regeneration include ALA, CoQ10, Resveratrol, NAC, selenium, zinc and the B and C vitamins. Limited clinical studies with the supplements have resulted in positive outcomes in late stage disease patients. In conclusion, effective prevention and treatment for diseases such as cancer, heart disease and immune deficiency will require multiple compounds. The safety and efficacy of these components on an individual component basis are the targets for a number of clinical trials. However, treating them as nutritional supplements may allow a multicomponent approach for the prevention and complementary treatment of cancer. 

 

3:00 pm - 3:30 pm
Break - Visit Exhibits

 

3:30 pm – 4:15 pm
Patient Lifestyle Coaching for Achieving Maximum Patient Treatment Plan Results
Paul Thompson, M.D.
CMO & CEO, Cenegenics, Fort Worth, TX
In the age-management approach to medicine one of the biggest hurdles is motivating the patient to change certain behaviors. As a society we have become spectators in our health as a opposed to active participants. We must motivate our patients through education to take an active role in their health, exercise, diet and cessation of certain abusive behaviors. Statistically less than 10% will make changes that will benefit them and decrease their risk of life threatening diseases, and improve the quality of their lives. We must use all available tools to accomplish this task education, personal challenges and even simple encouragement.

 

4:15 pm – 5:15 pm
Functional Testing Protocols for Clinical Use
Christian J. Renna, D.O.
Medical Director, Lifespan Medicine Clinic, Dallas, Tx
Functional medicine, focusing on biochemical individuality, provides physicians with an understanding of the underlying causes of patient complaints and also a view of factors that change before diseases manifest. Participants will learn how cutting-edge diagnostic tools provide the information for exploring biochemical individuality of patients within the construct of nutritional biochemisty, functional medicine, and the gene environment. This presentation is designed to instruct physicians and healthcare professionals on methods for integrating functional medicine to optimize the health and well-being of patients, including case studies and practical methods for incorporating functional medicine into their clinical practice.
 

 

5:15 pm – 6:00 pm
Pharmacokinetics and Dosing for Hormones including dose variation between dosage forms
Nayan Patel, Pharm D
Pharmacist in Charge, Central Drugs Compounding Pharmacy, Le Habra, CA
Using pharmacokinetic parameters we will discuss the dosing and variations between dosage forms of bio-identical hormone replacement therapies. Topical transdermal creams and gels vs. oral preparations, vaginal preparations vs. suppositories are all drug delivery considerations when prescribing bHRT.
 

 
Saturday, November 13
 
7:00 am - 7:45 am
Applying a Telomerase Activator as Part of a Health Maintenance Program - Results of the New Scientific Paper
Presented by Noel Patton
(includes complimentary breakfast)
Non-CME symposium sponsored by T.A. Sciences 
 
8:00 am – 8:45 am  
Overview of Hormone Testing - Serum, Saliva & Urine
Anna Cabeca, D.O.
CMO, Cabeca Health
CMO, Golden Isles Medical
Optimizing our patients' health requires a comprehensive review of their history, a physical exam, and appropriate testing. There are many available testing options and the physician should be able to reliably measure and adjust a patient's medical management accordingly. However, there are known limitations to testing hormones giving great variability and ultimately, as physicians, we are treating the patient and not the laboratory values. 

 

8:45 am – 9:30 am
Physiological Testing to Determine Optimal Cellular Function 
Naina Sachdev, M.D.
Medical Director, Advanced Aesthetics and Integrative Medical Center, Lake Oswego, OR
A critical evaluation of laboratory testing, both by blood and saliva, shall be discussed so that the clinician can understand subtle changes in these values that could represent less than optimal cellular function.  In addition to the general chemistries and CBC, other specific serum tests will be critically examined, such as, homocysteine, fibrinogen, ferritin, Plac-2, and hormone levels. For example, homocysteine discussions will not only include its place in cardiovascular and cerebrovascular disease but shall be expanded to demonstrate its elevation or low value interpretations that could represent difficulties with DNA transcription. A review of cellular physiology will ensue including the Kreb’s Cycle because of its extreme importance for our biochemistry. Saliva testing for both sex hormones and adrenal function will also be discussed. The attendee will obtain a good handle as to the optimal values expected for sex, age and patient history as opposed to the normal values reported out by the laboratories. Direction for this lecture will be to help the practitioner to be able to utilize this information for immediate access and usage in his/her daily practice towards the development of new sets of treatment protocols.  

 

9:30 am – 10:00 am
Break - Visit Exhibits

 

10:00 am – 11:00 am
IGF-1 Therapy: More Potent Than Growth Hormone Therapy To Reverse Aging?
Thierry Hertoghe, M.D.
President, International Hormone Society; European Academy of Quality of Life and Longevity Medicine (EAQUALL); World Society of Anti-Aging Medicine (WOSAMM)
Author, The Hormone Handbook
Growth hormone treatment of adults has gained wide recognition as the major hormone therapy that can oppose the progression of aging. But growth hormone acts in great part by stimulating the secretion of another hormone produced in the liver, insulin-like growth factor 1 or IGF-1. IGF-1 is at the base of most of the anabolic effects of growth hormone. But IGF-1 has some greater effects. It produces anabolic effects where growth hormone fails (in utero, aging liver of elderly persons, age-related growth hormone resistance, etc.) and reduces blood sugar levels, being a major antidiabetic hormone. Moreover, the association of growth hormone and IGF-1 may synergistically work in some patients to produce greater age-reversing effects

 
 
11:00 am – 12:00 pm
Hormonal Causes of Sexual Dysfunction
Lena Edwards, M.D., FAARFM 
President, Balance Health & Wellness Center, Lexington, KY
Medical Director, Seasons Salon and Spa, Lexington, KY
Community Faculty, University of Kentucky Medical Center
Paul Hueseman, Pharm D.
President, Bellevue Pharmacy  
Sexual Dysfunction is a pervasive problem which is infrequently addressed in a traditional medical setting. Additionally, pharmaceutical options for treatment of this condition are scant, particularly for women. In this discussion, we will review the primary etiologies of male and female sexual dysfunction. Clinical case studies will be presented to provide attendees with clinically relevant information which they can apply in their clinical practices. In addition to discussing basic hormone replacement as one treatment option for sexual dysfunction, we will also review the adjuvant compounded treatment options.

 

12:00 pm - 1:15 pm  
Lunch Break

 

1:15 pm – 2:00 pm 
Pros and Cons of HGH in Cardiovascular Disease
Enst R. von Schwarz, M.D., Ph.D.
Director, Cardiac Support Program, Cedars Sinai Medical Center, Los Angeles, CA
Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
Growth hormone (GH) is an anabolic hormone released from the anterior pituitary that regulates somatic growth.  Indirectly, and clinically most significant, GH stimulates the production of insulin-like growth factor-I (IGF) in the liver (endocrine action) and in peripheral tissue states of growth hormone (GH) and testosterone deficiency have been detected among a proportion of HF patients, which usually is not addressed.  Patients with idiopathic dilated cardiomyopathy (DCM) who present with HF have lower levels of circulating GH and IGF compared to healthy controls. Similar low baseline levels of GH and IGF were found in patients with moderate HF caused by myocardial ischemia. Of interest, others unveiled contradictory results, elevated levels of GH in patients with HF.  Because the elevated levels of GH were not all immunologically functional, low levels of IGF existed in these patients lending to the term ‘growth hormone resistance’. This phenomenon occurs primarily in HF patients with coexistent cardiac cachexia. Preliminary data on GH therapy in patients with heart failure for symptom improvement is promising, however, further large randomized control trials are warranted before definitive conclusions can be drawn.

 

2:00 pm – 3:15 pm
Current Status of Diagnosing and Treating Adult Growth Hormone Deficiency  
Jeffry Life, M.D., Ph.D.   
Principal & Senior Affiliate, Cenegenics Medical Institute, Las Vegas, NV
Lecture provides insight into the signs and symptoms of growth hormone deficiency we see in our patient population. In addition, the lecture will cover the recent changes in the prescribing information that the pharmaceutical industry has made which now require the use of provocative testing to accurately diagnose growth hormone deficiency. An overview of the approach I use in my practice for diagnosing and treating growth hormone deficiency will also be discussed.   

 

3:15 pm - 4:00 pm 
Break - Visit Exhibits

 

4:00 pm – 5:00 pm
Clinical Options and Applications for Genetic Testing
Professor Francesco Marotta, M.D, Ph.D.
Consulting Professor, WHO-affiliated Center for Biotechnology, University of Milano, Milano, Italy
Co-Founder, ReGenera Research Association for Aging Intervention, Italy
Editor-n-Chief, International Journal of Probiotics & Prebiotics
From the human genoma project conclusion, a post-genomic era has started, which represents an ideal match with tailored nutraceuticals, thus leading to a nutrigenomics evolution. Nutrigenomics mainly aims at studying genetic and epigenetic interactions with a nutrient as to lead to a phenotype change and therefore to the cell metabolism, differentiation or apoptosis. Such assessments has to be in line with consistent markers identification, both directly connected (functional factors) to the process to be modified as well as indirectly associated (indicators). In this context, it is of paramount importance aiming the integration into medical practice of new clusters of genomic test and possibly microbiome tests too aimed to predict risk assessment and better management. This would play a definite role in general good health conditions as well as in the potential reduction of disease risk occurrence within a synergistic-integrated approach in established therapeutic regimens.

 

5:00 pm – 6:00 pm
Importance of Estrogen Detoxification: “What goes in, must come out!”
Rebecca Murray, APRN, MSN, FNP, CDE 
Co-founder and Clinical Director, CT Holistic and Integrative Medicine, Groton, CT 
Assistant Clinical Professor of Nursing, Yale University, New Haven, CT 
Founder and Lecturer, Health Quest International, Norwich, CT
The rise in hormonal-related cancers is a concern to both practitioners and patients. We all know it is better to "prevent" a cancer than try to treat a cancer but the tools to assess our patients for their "risk" for an estrogen-related cancers has eluded us until recently.  We are now able to assess for and measure the amount of exposure to "estrogen mimicker" molecules within the body, evaluate the way the body metabolizes estrogen into the various categories of metabolites (whether they would be protect or harmful.....much the same way we evaluate the fractionation of a lipid profile).  We are also able to identify genetic polymorphisms (in addition to BRCA 1 and 2) in terms of assessing the risk associated with problems with detoxification and elimination of xenoestrogens and estrogen metabolites. The accumulation of these "carcinogenic metabolites" increase the risk of cancers but research has shown that in the world of "nutri-genomics", various nutrients can have an extremely positive effect on modulation of  stimulation of estrogen receptors IF WE KNOW WHAT THE PROBLEM IS. The purpose of this lecture is to review the physiology of estrogen metabolism, the availability of genetic testing associated with estrogen metabolism and detoxificiation, and the nutrients that have been shown to produce positive effects in terms of lowering the "total estrogenic burden" in the body and thereby reducing the risk of hormonal-related cancers. 

 

  
Sunday, November 14
 
7:00 am - 7:45 am
Age Management Medicine Physicians and the Malpractice Liability Insurance Dilemma
John Rush, M.D.
(includes complimentary breakfast)
Non-CME symposium sponsored by Longevity Physicians Insurance Company
 
 
8:00 am – 10:00 am
Healthier Aging with Two Potent Hormone Therapies: Oxytocin (for healthier emotional and sexual aging) and Vasopressin (for healthier skin aging)
Thierry Hertoghe, M.D.
President, International Hormone Society and, European Academy of Quality of Life and Longevity Medicine (EAQUALL), World Society of Anti-Aging Medicine (WOSAMM)
Author, The Hormone Handbook
Oxytocin is increasingly used for indications other than breastfeeding or delivery, indications where other treatments have failed and where it may have remarkable efficient effects: autism, drug addiction, depression, lack of warmheartedness, social phobia, lack of sociability, female orgasm, ejaculation, and even coronary heart disease and possibly breast cancer. How to work with this ‘safe’ hormone is explained in this presentation: doses, benefits and risks, follow-up.Vasopressin is traditionally used to reduce hemorrhagia and polyuria. A new indication seems to becoming increasingly validated: water retention in the skin, offering an anti-wrinkle effect, which is greater and safer than the use of botox. Detailed clinical information supported by pictures of vasopressin deficiency signs in patients and solid evidence-based data in the effects of vasopressin to oppose unnecessary aging is provided in this lecture to make the physician able to correct vasopressin deficiency in his patients, while being able to support his interventions by scientific studies.
 
10:00 am – 10:15 am 
Break 
 
10:15 am – 11:15 am
Traumatic Brain Injury – Hormonal Dysfunction Syndrome: “The Stealth Syndrome”
Mark L. Gordon, M.D.
Medical Director, Millennium Health Centers, Inc.
Clinical Professor, USC Keck School of Medicine
Medical Director, CBS Studios, Medical Consultant, NBC, HBO, CBS
According to the CDC there are over 1.9 million cases of non-combatant Traumatic Brain Injury a year. Of that number 53,000 individuals die on the spot, 360,000 end up in a hospital and nearly 1.5 million deal with the injury at home never knowing that there is a potential time-bomb ticking inside them. Unique to mild, moderate, and severe head injuries is the unforeseen development of hormone deficiencies – the stealth syndrome. This is caused by the interruption of the control mechanism found within the brain in the Hypothalamus. It is this area that controls the master gland - the Pituitary. It is the Pituitary Gland that produces all the hormones that regulate the glands found throughout our body - Thyroid, Ovaries, Testicles, and Adrenal Glands. Traumatic Brain Injury is now being recognized as a causative factor for accelerated hormonal deficiencies. This can cause Psychological, Physiological, and Physical manifestations like; depression, anxiety, mood swings, memory loss, inability to concentrate, learning disabilities, sleep deprivation, increased risk for heart attacks, strokes, high blood pressure, diabetes, loss of libido, menstrual irregularities, pre-mature menopause, obesity, loss of lean body mass, muscular weakness, and a number of other medically documented conditions. Studies have shown us that the use of conventional medications (antidepressants, antianxiety, antiseizure, and antipsychotic) do not improve upon the underlying cause creating the symptoms associated with Traumatic Brain Injury (Post-Concussion Syndrome) because they do nothing to increase the missing hormones. Psychotherapy does nothing to increase deficient hormones; it only encourages you to accept a poor quality of life and to move on. 
 
11:15 am – 12:15 pm
Long Term Use of Testosterone: Balancing the Risks and Rewards in Patients With Cardiovascular Disease, BPH, and Prostate Cancer
Kenneth Janson, M.D., FACS
Senior Attending Staff, Northwestern Lake Forest Hospital, Lake Forest, IL
Staff Physician, Cenegenics Chicago
Controversies surrounding the widespread use of testosterone supplementation in men (and women) have been the subject of intense debate. Over the years, testosterone abuse, as well as HGH abuse, have created legitimate concerns. Inappropriate therapies have caused multiple well-recognized medical, psychological and social problems.   However, during the past decade, much scientific data has been accumulated regarding safety and risk profiles, allowing the informed practitioner to now utilize testosterone replacement therapy in a manner that provides multiple benefits with minimal risk. This presentation will review the controversies associated with prostate cancer, BPH and cardiovascular disease, providing guidelines to assure maximum benefits and safety with testosterone supplementation. 

12:15 pm – 1:00 pm
Supercentenarians: Is There a Limit to Human Lifespan?
L. Stephen Coles, M.D., Ph.D.
Director, Supercentenarian Research Foundation
Lecturer, UCLA Department of Chemistry and Biochemistry (Molecular Biology Institute)
Visiting Scholar, Stanford University Department of Developmental Biology
For more than ten years, with the help of over 40 correspondents throughout the world, The Los Angeles Gerontology Research Group (GRG) has maintained a list of the World's Oldest Living People or Supercentenarians (persons 110 or older) on its Internet website (www.grg.org). We have come to be regarded by the international media (AP, UPI, and Reuters) as the world authority on this list due to our rigorous criteria for validating claims. In particular, we require three independent forms of documentation (Birth Certificates, Marriage Certificates, and PhotoID's) before adding someone  to our tables. Although the number of persons on the list goes up and down several times a week, we currently cite 73 Supercentenarians (71 Females: 2 Males) on our list (called Table E). The Supercentenarian ResearchFoundation (SRF), which we founded three years ago with the aim of sequencing the DNA Supercentenarians, has performed nine autopsies to uncover why these rare individuals die when they do, and how they escape from conventional diseases written on Death Certificates (Heart Disease, Cancer, Stroke, Diabetes, and Alzheimer's Disease). The common disease process for most of them is called Senile TTR Amyloidosis.  Two of them died of pneumonia. We have now begun the process of tissue sampling of families of Supercentenarians throughout the US and will begin sampling European Supercentarians in 2011.
 
  
ICMS 1-Day Training Course: Essential Knowledge in the Collection, Isolation and Therapeutic Uses of Stem Cells
(additional registration required – non CME)
 
This one day certification in the essential knowledge in the collection of stem cells is taught by pre-eminent experts in the field of cell-based medicine. Ranging from a general overview of the clinical uses of stem cells to best practices in the collection of stem cells, this training session is intended for licensed physicians who are interested in bringing cell-based medicine into their clinical practice. This course provides a critical introduction to the therapeutic options of stem cells and essential knowledge on the proper techniques for their effective collection.
 
8:00 am  – 8:15 am      
Working with an Institutional Review Board
David L. Harshfield, M.D.
Medical Director and Chief Radiologist, Westside and Northside Open MRI & Diagnostic Centers, Little Rock, AR
 
8:15 am  – 9:45 am
Platelet Rich Plasma
Joseph Aiello, D.O.
CMO, San Diego Center for Integrative Medicine
 
9:45 am – 10:00 am      
Patient Candidacy and Informed Consent
Keith L. March, M.D., Ph.D.
Associate Professor of Medicine, Indiana University School of Medicine
Director, Indiana University School of Medicine Combined Degree Program and Center for Vascular Biology and Medicine
 
10:00 am  – 10:15 am      
Break
 
10:15 am  – 11:45 am  
Peripheral Blood
Lee F. Clough, R.N., HP (ASCP)
Director of Clinical Affairs and Apheresis, NeoStem, New York, NY
 
11:45 am  – 12:00 pm  
The ICMS Registry
Francesco Vitelli, Ph.D.
Adjunct Assistant Professor, Texas A&M Health Science Center, Houston, TX
Senior Vice President of Operations & Technology, Stematix, Houston, TX
 
12:00 pm  – 1:00 pm
Lunch Session
Practice of Medicine: Physicians, Stem Cells and the Current Regulatory Environment
Mitchell Fuerst, Esq.
Founding Member & Managing Partner, Fuerst, Ittleman Attorneys and Counselors at Law, Miami, FL
 
1:00 pm – 2:30 pm      
Adipose Tissue
Vasilis Paspaliaris, M.D.
Director / Founder, AdiStem, Hong Kong
Visiting Professor, Institute of Integrative Medicine, Indian Open University, Calcutta, India
 
2:30 pm  – 2:45 pm
Break
 
2:45 pm  – 4:15 pm
Bone Marrow
Christopher J. Centeno, M.D.
Medical Director, Centeno-Schultz Clinic, Broomfield, CO
John R. Schultz, M.D., D.A.B.P.M.
Co-Medical Director, Centeno-Schultz Clinic, Westminster, CO
Ronald W. Hanson, Jr., M.D.
Family & Sports Specialist, Quello Clinic, Burnsville, MN
Clinical & Course Ultrasound Instructor, Sonosite, Inc.
 
4:15 pm  – 5:00 pm    
Examination
 

 

 

Conference Videos


 

Diamond Sponsor

Gold Sponsor

 

 

Home  |  About Us  |  Contact Us   |  

Privacy Statement   |  Terms Of Use   |  Copyright 2017 by Age Management Medicine Group   |  Login